Good example here are check point inhibitors like Keytruda , as a side effect immune system may start to attack healthy organs in those patients , producing autoimmune reaction , sometime fatal .

There was a patient after organ transplant who developed GvHD while on checkpoint inhibitor ..

I believe that if those patients on checkpoint inhibitors will also be place on Leronlimab there will be much less problems with patients , if any .

I discussed that once with Dr NP and he told me they talked about it in the past , but right now they want to concentrate on HIV , cancer and soon GvHD .

Yes , many other places where most probably our Leronlimab will be use in the future ..,